has reported that GSK
opened a £70 million expansion at an antibiotics factory, enabling the pharma giant to make antibiotics for an extra 100 million patients each year at the plant in Irvine, North Ayrshire. The site has been expanded to meet growing demand from the developing world and emerging markets and the investment creates 55 new jobs with a 35% boost in capacity. The expansion is part of GSK’s £280 million investment in Scotland since 2013 between its sites in Irvine and Montrose, Angus. Also, an additional £200 million of investment funding was announced at the opening.